RE:RE:Quiet may be good The Test turned out to have a fundamental flaw, not an advantage to target the Spike protein while everyone else targeted the N Protein.
Then SONA claims to know more than the NML about virology saying NML is testing their test wrong because they are the only targeting the Spike protein..
May seem obvious since the Spike protein is on the outside of the Virus.
AM: In the case of SARS-CoV-2, most serology tests are based on detecting antibodies against either the N protein or the S protein. Can you explain the differences between these two proteins and what makes them suitable as target antigens? IV: Coronavirus has four main structural proteins: nucleocapsid (N), spike (S), membrane (M) and envelope (E). The S protein consists of the S1 and S2 subunits. The S protein is highly immunogenic since it is located on the surface of the virus. The N protein plays an important role in the transcription and replication of viral RNA, packaging the encapsidated genome into virions and inhibits the cell cycle process of the host cells. The N protein is abundantly expressed during infections and also has high immunogenic activity. Therefore, both N and S protein could be potential targets for the antibody-based detection of SARS-CoV-2. However, the N protein homology between SARS-CoV-2 and SARSCoV-1 is 90 percent, compared with the S protein (77 percent), especially the S1 subunit including the RBD (66 percent). MikeyH wrote: You really, really need to stop kidding yourself. If they can't get V1 past HC, they have absolutely zero chance with the saliva test (which is almost certain to be even more challenging wrt sensitivity). And as for the FDA, they didn't even get to the starting line!!
This is just bleed out slowly as the bagholders cling on, praying for a miracle that will never arrive.